Skip to content

Clinical trials

Phase 1/2 Carcinoma, Hepatocellular trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 1/2 Country / region: Italy Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20142
20161
20171
20192
20221
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
Eisai Inc.2
BeOne Medicines1
Celgene1
Daiichi Sankyo1
GlaxoSmithKline1
Kymab Limited1
National Cancer Institute, Naples1
Novartis Pharmaceuticals1
Polaris Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular13
Colorectal Neoplasms3
Melanoma3
Neoplasms3
Endometrial Neoplasms2
Liver Neoplasms2
Squamous Cell Carcinoma of Head and Neck2
Stomach Neoplasms2
Uterine Cervical Neoplasms2
Biliary Tract Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.